Panacea Biotec Limited (PANACEABIO.BO)
INR 465.0
(2.69%)
INR 465.0
(2.69%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 57.1 Million | -4.22 Billion | -1.08 Billion | 1.06 Billion | -304.7 Million | 1.04 Billion |
| Net Income | -11.7 Million | 128.05 Million | 14.49 Billion | -1.45 Billion | -1.77 Billion | 462.25 Million |
| Depreciation & Amortization | 367.1 Million | 391.23 Million | 437.77 Million | 460.74 Million | 441.35 Million | 550.32 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 102.2 Million | -3.36 Billion | 3 Billion | 219.08 Million | -974.96 Million | 1.27 Billion |
| Other non-cash items | 62.5 Million | -1.37 Billion | -19.02 Billion | 1.83 Billion | 2 Billion | -1.23 Billion |
| Investing Cash Flow | 18.5 Million | 4.3 Billion | 12.82 Billion | -476.79 Million | -347.6 Million | -52.7 Million |
| Investments in PPE | -777.2 Million | -409.46 Million | -125.1 Million | -217.63 Million | -69.11 Million | -47.83 Million |
| Acquisitions | 66.8 Million | 395.05 Million | 18.22 Billion | 55.9 Million | 700 Thousand | -820 Thousand |
| Investment purchases | -3.47 Billion | -8.67 Billion | -10.49 Billion | -1.5 Billion | -452.93 Million | -37.74 Million |
| Sales/Maturities of investments | 4.2 Billion | 12.87 Billion | 5.17 Billion | 1.11 Billion | 720 Thousand | 20.29 Million |
| Other Investing Activities | 879.5 Million | 115.61 Million | 52.8 Million | 76.87 Million | 173.02 Million | 13.4 Million |
| Financing Cash Flow | -2.4 Million | -183.73 Million | -11.75 Billion | -471.1 Million | 907.39 Million | -1.01 Billion |
| Debt repayment | -2.4 Million | -147.74 Million | -7.86 Billion | -489.14 Million | -6.39 Billion | -347.5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 320 Million | - |
| Other Financing Activities | -25.7 Million | -35.99 Million | -3.89 Billion | 18.04 Million | 6.97 Billion | -663.9 Million |
| Accounts receivables | 29.6 Million | 68.94 Million | -463.4 Million | -168.57 Million | 180.79 Million | 177.07 Million |
| Accounts payables | - | - | - | 235.08 Million | -496.89 Million | 75.06 Million |
| Inventory | 241.6 Million | 106.3 Million | -385.8 Million | -264.45 Million | -662.64 Million | 847.63 Million |
| Other working capital | -169 Million | -3.54 Billion | 3.85 Billion | 417.02 Million | 3.78 Million | 173.45 Million |
| Cash at beginning of period | 398.52 Million | 503.5 Million | 520.79 Million | 402.18 Million | 144.66 Million | 164.37 Million |
| Cash at end of period | 1.39 Billion | 398.52 Million | 503.5 Million | 520.79 Million | 402.18 Million | 144.66 Million |
| Capital Expenditure | -777.2 Million | -409.46 Million | -125.1 Million | -217.63 Million | -69.11 Million | -47.83 Million |
| Effect of forex changes on cash | - | -40 Thousand | -130 Thousand | -1.14 Million | 2.43 Million | -3.57 Million |
| Net cash flow / Change in cash | 996.28 Million | -104.98 Million | -17.29 Million | 118.61 Million | 257.52 Million | -19.71 Million |
| Free Cash Flow | -720.1 Million | -4.63 Billion | -1.2 Billion | 850.01 Million | -373.81 Million | 1 Billion |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.3 Million | -11.7 Million | -22 Million | -82.9 Million | 109.8 Million | 128.05 Million |
| Depreciation & Amortization | - | 367.1 Million | 91.1 Million | 93.1 Million | 94.8 Million | 391.23 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 102.2 Million | - | - | - | -3.36 Billion |
| Other non-cash items | 14.3 Million | 62.5 Million | 22 Million | 82.9 Million | -109.8 Million | -1.37 Billion |
| Investing Cash Flow | - | 18.5 Million | - | - | - | 4.3 Billion |
| Investments in PPE | - | -777.2 Million | - | - | - | -409.46 Million |
| Acquisitions | - | 66.8 Million | - | - | - | 395.05 Million |
| Investment purchases | - | -3.47 Billion | - | - | - | -8.67 Billion |
| Sales/Maturities of investments | - | 4.2 Billion | - | - | - | 12.87 Billion |
| Other Investing Activities | - | 879.5 Million | - | - | - | 115.61 Million |
| Financing Cash Flow | - | -2.4 Million | - | - | - | -183.73 Million |
| Debt repayment | - | -2.4 Million | - | - | - | -147.74 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -25.7 Million | - | - | - | -35.99 Million |
| Accounts receivables | - | 29.6 Million | - | - | - | 68.94 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | 241.6 Million | - | - | - | 106.3 Million |
| Other working capital | - | -169 Million | - | - | - | -3.54 Billion |
| Cash at beginning of period | - | 398.52 Million | 370.5 Million | 454.2 Million | 398.52 Million | 503.5 Million |
| Cash at end of period | - | 1.39 Billion | 552.7 Million | 370.5 Million | 109.1 Million | 398.52 Million |
| Capital Expenditure | - | -777.2 Million | - | - | - | -409.46 Million |
| Effect of forex changes on cash | - | - | - | - | - | -40 Thousand |
| Net cash flow / Change in cash | - | 996.28 Million | 182.2 Million | -83.7 Million | -289.42 Million | -104.98 Million |
| Free Cash Flow | - | -720.1 Million | 182.2 Million | -83.7 Million | 109.1 Million | -4.63 Billion |
6301
8898
DMKPQ
5133
PES
DNLI